• 目的研究低分子肝素对不稳定心绞痛疗效

    The objective is to study the effect of Fragmin in treatment of unstable angina.

    youdao

  • 目的探索亲和色谱纯化分子方法

    Purpose To study purification method of the low molecular weight heparin(LMWH) by affinity chromatography.

    youdao

  • 目的观察低分子肝稳定心绞痛疗效

    Objective:To study the effect of Fragmin in treatment of unstable angina.

    youdao

  • 低分子肝素治疗急性梗死有效安全简便

    LMWH is efficacious, safe and simple for the treatment of acute cerebral infarction.

    youdao

  • 目的观察分子肝素治疗梗死有效性安全性

    Objective: To explore the safety and efficiency of low molecular heparin calcium treating cerebral infarction.

    youdao

  • 目的考察分子靶向球缓释性、稳定性靶向性。

    AIM To test gelatin microspheres of low molecular weight heparin (LMWH-GMS) release behavior; lung target behavior and stability.

    youdao

  • 结论分子肝素皮下注射治疗进展性脑卒中安全有效

    Conclusion Small molecule heparin is a safe and effective medicine for the treatment of progressive cerebral thrombosis.

    youdao

  • 目的探讨三种不同途径给予分子抗凝进行血液透析效果

    Objective To adopt three approaches of applying low molecule heparin as anticoagulant during blood hemodialysis.

    youdao

  • 目的探讨剂量尿激酶分子肝素治疗急性梗死疗效

    Objective To discuss the curative effect of the small dosage urokinase and the low molecular heparin calcium on cerebral infarction.

    youdao

  • 目的观察分子肝素预防小儿过敏性紫癜肾损害中的作用

    Objective To evaluate the therapeutical effect of low molecular heparin calcium in the prevention of Henoch-Schonlein purpura nephritis (HSPN).

    youdao

  • 目的观察地尔硫联合分子治疗慢性肺源性心脏病疗效

    Objective To observe the curative effect of diltiazem combined with low molecular weight heparins on chronic pulmonary heart disease (CPHD).

    youdao

  • 目的探讨分子肝素治疗过敏性紫癜预防紫癜性肾炎的作用。

    Objective To evaluate the effectivity of low molecular heparin calcium in treating Henoch-Schonlein purpura and preventing Henoch-Schonlein purpura nephritis(HSPN).

    youdao

  • 目的探讨皮下注射分子肝素局部按压与否局部出血关系

    Objective: To discuss the relations between partially pressing hypodermic injection of low molecular heparin and partial hemorrhage.

    youdao

  • 结果丁咯地尔疗效好,奥扎格雷分子肝素组次之。

    Result: The effect of buflomedil group was better than ozagrel group and low molecular heparin calcium group.

    youdao

  • 目的观察分子联合治疗进展性脑梗死疗效安全性

    ObjectiveTo observe the combined effect and safety of Sodium Ozagrel and Low Molecular Heparin in the treatment of progressive cerebral infraction.

    youdao

  • 目的观察分子肝素联合冠心宁治疗不稳定心绞痛临床疗效

    Objective To observe the curative effect on treatment of unstable angina with low molecular heparin calcium (LMHC) combined with Guanxinnin injection.

    youdao

  • 分子具有较高抗凝作用出血副作用一般肝素明显减少

    Low molecular heparin has the features of high anticoagulation and less side effect of bleeding as compares with the ordinary heparin.

    youdao

  • 前言:目的:探讨三种分子治疗不稳定性心绞痛经济效果

    Objective: To investigate the economics consequences of low molecular heparin in the treatment of UAP.

    youdao

  • 临床经验常常将低分子肝作为辅助疗法溶栓剂治疗急性心肌梗死

    Experience has been gathered using LMWHs as an adjunctive therapy with thrombolytics for acute myocardial infarction.

    youdao

  • 剂量分子胃肠外营养生长联合应用具有较佳的疗效。

    Small dosage of low molecular weight heparin, parenteral nutritional support and somatostatin therapy have the therapeutical effects to some extent.

    youdao

  • 方法病人随机分成低分子肝素阿斯治疗阿斯匹林对照组

    Methods: Patients were randomly divided into LMWH plus aspirin treatment group and aspirin control group.

    youdao

  • 目的研究人工髋关节置换术使用分子预防静脉血栓安全性

    Objective: to investigate the safety of low molecular weight heparin to prevent deep venous thrombosis after primary hip replacement surgery.

    youdao

  • 目的观察血栓通注射液联合分子钙治疗不稳定型心绞痛临床疗效

    Objective To study the clinical effects of Xueshuantong with low molecular weight heparin for unstable angina(UA).

    youdao

  • 目的:评价低分子(LMWH)治疗急性缺血性中风疗效安全性

    AIM: To study the effect and safety of low-molecular-weight heparin (LMWH) in the treatment of acute ischemic stroke.

    youdao

  • 目的探讨低分子肝素(LMWH)冠状动脉支架术中的应用价值及安全性。

    Objective To explore the application of low-molecular-weight heparin (LMWH) in the procedure of coronary stent implantation.

    youdao

  • 结论应用低分子肝素联合尿激酶治疗频发TIA一种有效安全治疗方法。

    Conclusion The use of LMWH combined with urokinase in treating recurrent TIA was an efficacious treatment with good security.

    youdao

  • 目的观察分子联合血管转换酶抑制剂糖尿病肾病显性蛋白尿治疗效果

    Objective To investigate the effects of the combination of low molecular weight heparin and ACEI on albuminuria in diabetic nephropathy.

    youdao

  • 目的观察舒血宁注射液联合分子治疗不稳定心绞痛(uap)临床疗效。

    Objective to investigate the therapeutic effect of Shuxuening injection combined with low molecular heparin in treating of unstable angina pectoris (UAP).

    youdao

  • 目的评价分子联合大剂量纳洛酮治疗早期急性梗死临床疗效安全性

    AIM: To evaluate the therapeutic effect and safety of low molecular weight heparin calcium combined with naloxone on acute cerebral infraction in early stage.

    youdao

  • 方法对比使用使用分子肝素血液透析中的抗凝效果,透析效果及其副作用

    Methods Compare the effect on anticoagulant therapy, hemodialysis and the side effect from the use of heparin with those from the use of Low Molecular Weight Heparins.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定